Orthotopic & Metastatic Xenograft Studies in the SRG Rat

Time: 11:45 am
day: Day Two


The SRG rat is an ideal highly immunodeficient xenograft host which provides advantages for preclinical in vivo drug efficacy studies including higher tumor takerates, serial tumor biopsies, and combination metabolism/safety studies. Hera
will present data on novel applications of the SRG rat including metastatic and orthotopic tumor models